Selinexor for relapsed or refractory diffuse large B-cell lymphoma: examining the artifact - Authors' reply

Lancet Haematol. 2020 Oct;7(10):e707-e708. doi: 10.1016/S2352-3026(20)30300-8.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Artifacts*
  • Humans
  • Hydrazines
  • Lymphoma, Large B-Cell, Diffuse*
  • Triazoles

Substances

  • Hydrazines
  • Triazoles
  • selinexor